tradingkey.logo
tradingkey.logo
Suchen

QuidelOrtho Corp

QDEL
Zur Watchlist hinzufügen
18.250USD
+0.070+0.39%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
1.24BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über QuidelOrtho Corp Unternehmen

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

QuidelOrtho Corp Informationen

BörsenkürzelQDEL
Name des UnternehmensQuidelOrtho Corp
IPO-datumFeb 01, 1991
CEOBlaser (Brian J)
Anzahl der mitarbeiter6600
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 01
Addresse9975 Summers Ridge Road
StadtSAN DIEGO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92121
Telefon18585521100
Websitehttps://www.quidelortho.com/
BörsenkürzelQDEL
IPO-datumFeb 01, 1991
CEOBlaser (Brian J)

Führungskräfte von QuidelOrtho Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
23.26K
+35.41%
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
9.35K
+73.02%
Dr. Mary Lake Polan, M.D., Ph.D.
Dr. Mary Lake Polan, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Kenneth Jon (Ken) Widder, M.D.
Dr. Kenneth Jon (Ken) Widder, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von QuidelOrtho Corp?

Die fünf größten Anteilseigner von QuidelOrtho Corp sind: Dr. Kenneth F. Buechler, Ph.D.

Wie viele Institutionen halten Anteile an QuidelOrtho Corp (QDEL)?

Mit Stand vom 2026Q1 halten 619 Institutionen Anteile an QuidelOrtho Corp, mit einem Gesamtmarktwert von etwa 88.33M, was 129.53% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -14180850.00 gestiegen.

Was ist die größte Einnahmequelle von QuidelOrtho Corp?

Am 2026Q1 erzielte das Geschäft mit Labs für QuidelOrtho Corp den höchsten Umsatz in Höhe von 373.80M, was 53.41% des Gesamtumsatzes entspricht.